MDS Purpose, Mission & Goals

Purpose

The purpose and objective of the Society shall be to advance the neurological sciences pertaining to Movement Disorders; to improve the diagnosis and treatment of patients; to operate exclusively for scientific, scholarly and educational purposes; to encourage research; to provide forums, such as medical journals, scientific symposia and International Congress, for sharing ideas and for advancing the related clinical and scientific disciplines; to encourage interest and participation in the activities of the Society among healthcare and allied professionals and scientists; and to collaborate with other related professional and lay organization.

Mission

The International Parkinson and Movement Disorder Society is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic Movement Disorders and abnormalities in muscle tone and motor control.

Goals

1. To disseminate knowledge about movement disorders by:
   1. Providing educational programs for clinicians, scientists and the general public designed to advance scientific and clinical knowledge about movement disorders
   2. Sponsoring International Congresses and Symposia on movement disorders
   3. Collaborating with other international organizations and lay groups
   4. Publishing journals, videos, and other collateral materials committed to high scientific standards and peer review
2. To promote research into causes, prevention and treatment of Movement Disorders by:
   1. Using the Society's influence and resources to enhance support for research
   2. Facilitating the dissemination of information about research
   3. Encouraging the training of basic and clinical scientists in movement disorders and related disorders
3. For the purposes of favorably affecting the care of patients with movement disorders, the Society will provide expertise, advice and guidance to:
   1. Regulatory agencies to assist them in the approval process of safe and effective therapeutic interventions
   2. The public (media) and patient support groups by informing them of new research and therapeutic advances
   3. Governments to assist them in the development of policies that affect support of research and patient care
   4. Educational efforts to assist in developing standards of training in the specialty